Why value “measurement” is critical to the future of the meetings industry development Isabel Bardinet, CEO ESC JMIC, Paris, May 2015

The European society of Cardiology To reduce the burden of cardiovascular disease in Europe Speaker

ESC - European Society of Cardiology 1950: ESC founded by 14 National Societies 1952: First European Congress of Cardiology Since 1985: Centralised association administration and Congress organisation 1993: European Heart House built as official headquarters

ESC National Cardiac Societies ESC Affiliated Cardiac Societies 56 NCS ( members )38 affiliated societies 6 Associations 5 Councils 15 Working Groups ESC Fellows and Nurse Fellows

How does the ESC interact with the Meetings Industry ? Congress organisation - a direct value ESC activities - indirect driving value Cardiovascular Disease – a societal factor Speaker

Direct Impact Metrics Usually Considered Number of Congress participants and countries Sessions Abstracts Rooms Sqm Days Hotel nights Speaker

ESC congress 2014 Abstracts submitted Abstracts selected Lecture rooms Number of sessions Expo m² occupied Total sqm occupied Satellite Symposia Hands on Tutorials Active Delegates Total Attendance

Speaker

ESC Primary Activities Education & Scientific resources Journals, publications, courses and leading European congresses Membership National Cardiac Societies, Associations, Working Groups, Councils, Fellows of the ESC (FESC) Surveys and registries EURObservational Research Programme - reliable data collection on CVD Clinical Practice Guidelines Recommendations for diagnosis & therapy European Affairs Political Advocacy, European Union, Health Organisations Global Affairs Increase outreach and impact with international organisations

Indirect Driving Factors Education & Scientific resources 12 Journals, European Heart Journal is the flagship N°2 with IF manuscripts per annum with a 12% acceptance rate Publications 4 textbooks, handbooks Distance learning platform and webinar courses Membership 90,000 Members 56 National Cardiac Societies, 6 Associations, 15 Working Groups 5 Councils, Fellows and Nurse Fellows and 38 affiliated societies Late breaking clinical trials this year 233 for 70 accepted Clinical practice Guidelines 1.2 million downlaods in 2014 Recommendations for diagnosis /therapy clarify areas of consensus and disagreement, allowing distribution of the best possible guidance to practicing physicians 4 to 5 published per year

Indirect Driving Factors Registries Registries are essential to assess CV epidemiology, diagnostic/therapeutic processes and adherence to Guidelines. 20 different registries Over centres with patients More than 100 publications Over 70 countries already participating Certification / Revalidation The ESC offers cardiology practitioners a range of certifications to test and assess their knowledge, skills and performance in their practice following post-graduation, educational and training experiences. ESC certifications are both a proof of professional excellence to the patients and a way for practitioners to enhance their good practice. Health economics – outcome measurement Speaker

Societal factors All of these activities are driven by societal factors Speaker

European CVD Statistics 2012 Each year cardiovascular disease causes over 4 million deaths in Europe and over 1.9 million deaths in the European Union (EU). CVD causes 47% of all deaths in Europe and 40% in the EU. CVD is the main cause of death in women in all countries of Europe and is the main cause of death in men Speaker

CVD Health Industry in Europe Overall CVD is estimated to cost the EU economy almost €196 billion a year. Of the total cost of CVD in the EU, around 54% is due to health care costs, 24% due to productivity losses and 22% due to the informal care of people with CVD. Speaker

Global Distribution of Deaths from Non-Communicable Diseases

Cumulative Contribution to Life Expectancy Increase, 1970–2000

CVD Health Industry Worldwide Economists project that the cost of not investing in CVD prevention and treatment could amount to as much as $47 trillion worldwide in the next 25 years. This loss is potentially avoidable because the prescribed World Health Organization (WHO) “best buy” interventions only cost $11 billion to $13 billion annually. The consequences will be more severe in developing countries, given that 80% of cardiovascular deaths occur in LMIC countries. Speaker Projected economic loss of NCDs in LMIC countries worldwide, 2011 to 2025

ESC congress 2014 Abstracts submitted Abstracts selected Lecture rooms Number of sessions Expo m² occupied Total sqm occupied Satellite Symposia Hands on Tutorials Active Delegates Total Attendance

Value driving factors Measurement or assessment ? Value for whom? Meetings Industry Association /organiser Society But above all value coming from where ? => value assessment criteria These should not be restricted to the meetings industry criteria

No more coffee cups and hotel beds please !! Speaker

Value assessment for the meetings industry You can have a Passive or an interactive attitude : Wait and see what comes or observe and adapt But to adapt you need to know to show and to project Speaker

”The great thing in this world is not so much where we stand as in what direction we are moving” Oliver Wendell Holmes

Thank you for your attention and for the opportunity of presenting our side of the iceberg ! Speaker